New Personalized Therapy Aims to Improve Tamoxifen Effectiveness Breast cancer remains the most common cancer among women worldwide, and hormone receptor–positive cancers account for a significant portion of cases. In a notable advance, researchers at the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP) have developed a personalized therapy designed to boost the effectiveness of…